School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Danlan Public Welfare, Beijing, China.
PLoS One. 2023 Oct 19;18(10):e0293297. doi: 10.1371/journal.pone.0293297. eCollection 2023.
Men who have sex with men (MSM) are at high risk of HIV acquisition. Long-acting injectable-pre-exposure prophylaxis (LAI-PrEP), requiring less frequent dosing, is being studied as an alternative method to daily oral HIV PrEP. With the addition of this potential new prevention method, it expands the scope for a wider user choice and is expected to increase the acceptability and uptake of HIV prevention measures. The aim of our study was to explore the willingness to use LAI-PrEP and associated influential factors.
Participants were recruited from December 2020 to March 2021 through banner advertisements on web- and mobile app-based platforms on Blued, a large gay Chinese social media platform. MSM in our cross-sectional study was HIV-negative and currently lived in mainland China. Participants were asked about their willingness to use LAI-PrEP and reasons why they might be or not be willing to use LAI-PrEP. Multivariable logistic regression was used to analyze the factors associated with the willingness to use LAI-PrEP.
In total, 969 participants met the inclusion criteria and finished the survey. Nearly twenty percent (19.5%) of participants had never tested for HIV; 66.8% of MSM had multiple male partners; and 51.6% of MSM engaged in condomless sex with their partner. About three-fifths (66.3%) of MSM were aware of PrEP, and only 3.9% of MSM had used PrEP before. The willingness to use LAI-PrEP among MSM was 74.0% (95% CI: 71.4%-76.6%). MSM with higher education levels were less likely to show a willingness to use LAI-PrEP (AOR = 0.56, 95%CI: 0.38-0.84). Participants who had a history of HIV test (AOR = 1.68, 95%CI: 1.11-2.55), were willing to use daily oral PrEP (AOR = 10.64, 95%CI:7.43-15.21), had multiple male sexual partners (AOR = 1.33, 95%CI:0.93-1.90), who used rush popper(AOR = 1.49, 95%CI:1.05-2.13), and who were aware of PEP (AOR = 1.66, 95%CI: 1.02-2.70) were more likely to show willingness to use LAI-PrEP.
In our study, MSM had quite high awareness but low uptake of PrEP. As LAI-PrEP is expected to be approved for use in China in the future, our study of MSM highlights the need for key population-focused education programs about PrEP and healthy sexual behavior. This study also provides some evidence for LAI-PrEP use among the Chinese MSM population in the future.
男男性行为者(MSM)感染艾滋病毒的风险很高。长效注射型 HIV 暴露前预防(LAI-PrEP)作为一种替代每日口服 HIV 预防药物的方法,其用药频率较低,正在被研究。随着这种潜在的新预防方法的加入,扩大了更广泛的用户选择范围,预计将提高 HIV 预防措施的可接受性和采用率。我们的研究旨在探讨使用 LAI-PrEP 的意愿及其相关影响因素。
2020 年 12 月至 2021 年 3 月,我们通过在 Blued 上的网页和移动应用程序平台上发布横幅广告招募参与者,Blued 是一个大型的中国同性恋社交媒体平台。本横断面研究中的 MSM 为 HIV 阴性,且目前居住在中国内地。参与者被问及他们使用 LAI-PrEP 的意愿,以及他们可能愿意或不愿意使用 LAI-PrEP 的原因。多变量逻辑回归用于分析与使用 LAI-PrEP 意愿相关的因素。
共有 969 名参与者符合纳入标准并完成了调查。近 20%(19.5%)的参与者从未接受过 HIV 检测;66.8%的 MSM 有多个男性性伴侣;51.6%的 MSM 与伴侣发生过无保护性行为。约五分之三(66.3%)的 MSM 知晓 PrEP,只有 3.9%的 MSM 曾使用过 PrEP。MSM 使用 LAI-PrEP 的意愿为 74.0%(95%CI:71.4%-76.6%)。受教育程度较高的 MSM 不太可能表现出使用 LAI-PrEP 的意愿(AOR = 0.56,95%CI:0.38-0.84)。有 HIV 检测史的参与者(AOR = 1.68,95%CI:1.11-2.55)、愿意使用每日口服 PrEP(AOR = 10.64,95%CI:7.43-15.21)、有多个男性性伴侣(AOR = 1.33,95%CI:0.93-1.90)、使用rush popper(AOR = 1.49,95%CI:1.05-2.13)和知晓 PEP(AOR = 1.66,95%CI:1.02-2.70)的参与者更有可能表现出使用 LAI-PrEP 的意愿。
在我们的研究中,MSM 对 PrEP 的知晓率很高,但使用率很低。由于 LAI-PrEP 预计未来将在中国获得批准使用,我们对 MSM 的研究强调了针对关键人群开展有关 PrEP 和健康性行为的教育计划的必要性。本研究还为未来中国 MSM 人群使用 LAI-PrEP 提供了一些证据。